![Bicycle Therapeutics PLC Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/bcyc.png?tr=w-200)
Bicycle Therapeutics PLC
NASDAQ:BCYC
![Bicycle Therapeutics PLC Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/bcyc.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/bcyc.png)
Bicycle Therapeutics PLC
Net Change in Cash
Bicycle Therapeutics PLC
Net Change in Cash Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/cnta.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/exai.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/autl.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/imcr.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/lse/gns.png)
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Net Change in Cash
$163.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Net Change in Cash
-$265.6m
|
CAGR 3-Years
-205%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Exscientia PLC
NASDAQ:EXAI
|
Net Change in Cash
-ÂŁ145.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Net Change in Cash
-$142.4m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Immunocore Holdings PLC
NASDAQ:IMCR
|
Net Change in Cash
ÂŁ40.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
![]() |
Genus PLC
LSE:GNS
|
Net Change in Cash
-ÂŁ300k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
See Also
What is Bicycle Therapeutics PLC's Net Change in Cash?
Net Change in Cash
163.7m
USD
Based on the financial report for Mar 31, 2024, Bicycle Therapeutics PLC's Net Change in Cash amounts to 163.7m USD.
What is Bicycle Therapeutics PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
24%
The average annual Net Change in Cash growth rates for Bicycle Therapeutics PLC have been 24% over the past three years .